JPWO2023010100A5 - - Google Patents
Info
- Publication number
- JPWO2023010100A5 JPWO2023010100A5 JP2024505469A JP2024505469A JPWO2023010100A5 JP WO2023010100 A5 JPWO2023010100 A5 JP WO2023010100A5 JP 2024505469 A JP2024505469 A JP 2024505469A JP 2024505469 A JP2024505469 A JP 2024505469A JP WO2023010100 A5 JPWO2023010100 A5 JP WO2023010100A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- cancer
- amino acid
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/109041 | 2021-07-28 | ||
| CN2021109041 | 2021-07-28 | ||
| CNPCT/CN2022/104562 | 2022-07-08 | ||
| CN2022104562 | 2022-07-08 | ||
| PCT/US2022/074286 WO2023010100A1 (en) | 2021-07-28 | 2022-07-28 | Novel anti-sirpa antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024531900A JP2024531900A (ja) | 2024-09-03 |
| JP2024531900A5 JP2024531900A5 (https=) | 2025-08-04 |
| JPWO2023010100A5 true JPWO2023010100A5 (https=) | 2025-08-04 |
Family
ID=85087323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505469A Pending JP2024531900A (ja) | 2021-07-28 | 2022-07-28 | 新規の抗ｓｉｒｐａ抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250270315A1 (https=) |
| EP (1) | EP4377358A4 (https=) |
| JP (1) | JP2024531900A (https=) |
| KR (1) | KR20240039006A (https=) |
| CN (1) | CN118076638A (https=) |
| AU (1) | AU2022317822A1 (https=) |
| CA (1) | CA3227854A1 (https=) |
| TW (1) | TW202313699A (https=) |
| WO (1) | WO2023010100A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120569409A (zh) * | 2023-01-18 | 2025-08-29 | 科望(苏州)生物医药科技有限公司 | 靶向sirpa和claudin 18.2的双特异性分子 |
| EP4702053A1 (en) * | 2023-04-27 | 2026-03-04 | LaNova Medicines Limited | Combination treatment targeting sirpa and claudin 18.2 |
| WO2025140296A1 (zh) * | 2023-12-26 | 2025-07-03 | 上海宏成药业有限公司 | 抗dll3抗体或其抗原结合片段及其用途 |
| KR20250164033A (ko) * | 2024-05-14 | 2025-11-24 | 주식회사 지놈앤컴퍼니 | 항-bcam 항체 및 이의 컨쥬게이트 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3334757A4 (en) * | 2015-08-14 | 2019-04-03 | Merck Sharp & Dohme Corp. | ANTI-Tigit ANTIBODY |
| KR20250079073A (ko) * | 2018-07-10 | 2025-06-04 | 고쿠리츠다이가쿠호진 고베다이가쿠 | 항 SIRPα 항체 |
| WO2021032078A1 (en) * | 2019-08-20 | 2021-02-25 | Elpiscience (Suzhou) Biopharma, Ltd. | Novel anti-sirpa antibodies |
| JP7437815B2 (ja) * | 2019-12-24 | 2024-02-26 | ラノバ メディシンズ リミテッド | 抗ＳＩＲＰαモノクローナル抗体およびその使用 |
-
2022
- 2022-07-28 KR KR1020247006211A patent/KR20240039006A/ko active Pending
- 2022-07-28 AU AU2022317822A patent/AU2022317822A1/en active Pending
- 2022-07-28 CA CA3227854A patent/CA3227854A1/en active Pending
- 2022-07-28 CN CN202280053002.XA patent/CN118076638A/zh active Pending
- 2022-07-28 TW TW111128255A patent/TW202313699A/zh unknown
- 2022-07-28 JP JP2024505469A patent/JP2024531900A/ja active Pending
- 2022-07-28 WO PCT/US2022/074286 patent/WO2023010100A1/en not_active Ceased
- 2022-07-28 EP EP22850533.5A patent/EP4377358A4/en active Pending
- 2022-07-28 US US18/292,922 patent/US20250270315A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024059609A5 (https=) | ||
| RU2017145150A (ru) | Антитело против pdl-1, его фармацевтическая композиция и применение | |
| JP2021514664A5 (https=) | ||
| JP2020501531A5 (https=) | ||
| JP2021531764A5 (https=) | ||
| JP2018526972A5 (https=) | ||
| WO2022171134A1 (zh) | 包含抗cldn18.2的抗体或其抗原结合片段的抗体药物偶联物及其用途 | |
| TW202221035A (zh) | 抗ilt2抗體及其用途 | |
| JP2019513410A5 (https=) | ||
| EP3241847A1 (en) | Her-2 binding antibodies | |
| WO2024088346A1 (en) | Anti-ccr8 antibodies and uses thereof | |
| JPWO2020244528A5 (https=) | ||
| JP7775345B2 (ja) | 抗ｇｆｒａｌ抗体およびその使用 | |
| JPWO2023010100A5 (https=) | ||
| TW202328183A (zh) | 人類介白素-4受體α抗體 | |
| JPWO2023116925A5 (https=) | ||
| CN121013865A (zh) | 抗cd180结合分子及其用途 | |
| JPWO2021063201A5 (https=) | ||
| CN119176876A (zh) | 抗b7-h4抗体及其应用 | |
| JPWO2023143263A5 (https=) | ||
| CN120936630A (zh) | Dll3抗体-药物缀合物和其用途 | |
| KR20240072932A (ko) | B7-h3에 특이적으로 결합하는 항체 | |
| JPWO2023010098A5 (https=) | ||
| JPWO2020218951A5 (https=) | ||
| RU2843348C2 (ru) | Антитело к GFRAL и его применение |